Is Structure Therapeutics Inc. overvalued?

Structure Therapeutics Inc. (GPCR) — key valuation metrics and fundamentals.

No verdict

Price

$35.26

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.03B

Dividend yield

0.0%

Return on equity

-16.9%

Sector

Healthcare

Fair value compares GPCR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks